Literature DB >> 10899280

Evaluating the cardiovascular tolerance for sex.

R F DeBusk1.   

Abstract

The cardiovascular tolerance for sex has largely been equated with physical activity, yet sexual arousal plays a major role. Exercise testing is useful, primarily for evaluating functional capacity, which reflects the extent of physical conditioning and the limitation imposed by symptoms of angina, dyspnea, and fatigue. Exercise testing, which is useful for evaluating functional capacity in sedentary patients, is generally unnecessary in physically active patients. Exercise testing, with or without radionuclide imaging, is of limited value in assessing the risk of future cardiovascular events-a limitation shared by all diagnostic tests, including coronary angiography. The absolute risks of coition-induced myocardial infarction (MI) or death are extremely low-on the order of 2 chances per million per hour in healthy middle-aged individuals or 20 chances per million per hour in "high-risk" patients with ischemic heart disease. This is equivalent to an annual risk of 1. 01% and 1.2%, respectively. Sex is a comparatively weak precipitant of acute coronary events, accounting for only 0.5-1.0% of all such events. The cardiovascular tolerance for sex in an individual can be characterized by the "functional reserve," that is, the extent to which the cardiovascular response to sex-measured by the heart rate, blood pressure, and oxygen consumption-encroaches on the peak response to exercise. Cardiovascular symptoms during sex rarely occur in patients who do not experience similar symptoms during exercise testing at a level equivalent to 6 METS.

Entities:  

Mesh:

Year:  2000        PMID: 10899280     DOI: 10.1016/s0002-9149(00)00894-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease.

Authors:  Stephen L Archer; Ferrante S Gragasin; Linda Webster; Derek Bochinski; Evangelos D Michelakis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Sudden cardiovascular death associated with sexual activity : A forensic autopsy study (1972-2004).

Authors:  Markus Parzeller; Roman Bux; Christoph Raschka; Hansjörgen Bratzke
Journal:  Forensic Sci Med Pathol       Date:  2006-06       Impact factor: 2.007

3.  The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease.

Authors:  Dean Patterson; Robert Kloner; Mark Effron; Jeffrey Emmick; Alun Bedding; Margaret Warner; Malcolm Mitchell; Simon Braat; Thomas MacDonald
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

4.  A prospective study of the effect of antihypertensive medications on the sexual functions of hypertensive adult male patients.

Authors:  Akinwumi Akinyinka Akinyede; Obiyo Nwaiwu; Olumuyiwa John Fasipe; Adedunni Olusanya; Sunday Olufemi Olayemi; Bisola Akande
Journal:  Future Sci OA       Date:  2020-06-02

Review 5.  Cardiovascular safety of sildenafil.

Authors:  Diane Tran; Laurence Guy Howes
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 6.  Assessment of cardiovascular risk in patients with erectile dysfunction: focus on the diabetic patient.

Authors:  Robert A Kloner
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 7.  Sexual function in hypertensive patients receiving treatment.

Authors:  Thorsten Reffelmann; Robert A Kloner
Journal:  Vasc Health Risk Manag       Date:  2006
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.